SH, C., JM, P., EH, L., YH, S., YJ, J., SB, C., & YS, H. (2025). High-resolution crystal structure of PD-1 in complex with retifanlimab, the FDA-approved immune checkpoint blocking antibody for treating Merkel cell carcinoma. Biochemical and biophysical research communications, 742, 151106. https://doi.org/10.1016/j.bbrc.2024.151106
Chicago Style (17th ed.) CitationSH, Cho, Park JM, Lee EH, Song YH, Jang YJ, Choi SB, and Heo YS. "High-resolution Crystal Structure of PD-1 in Complex with Retifanlimab, the FDA-approved Immune Checkpoint Blocking Antibody for Treating Merkel Cell Carcinoma." Biochemical and Biophysical Research Communications 742 (2025): 151106. https://doi.org/10.1016/j.bbrc.2024.151106.
MLA (9th ed.) CitationSH, Cho, et al. "High-resolution Crystal Structure of PD-1 in Complex with Retifanlimab, the FDA-approved Immune Checkpoint Blocking Antibody for Treating Merkel Cell Carcinoma." Biochemical and Biophysical Research Communications, vol. 742, 2025, p. 151106, https://doi.org/10.1016/j.bbrc.2024.151106.
